share_log

Canaccord Genuity Maintains Hold on Staar Surgical, Lowers Price Target to $43

Benzinga ·  May 8 13:00

Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $46 to $43.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment